Dr. Lu Xianping won the most influential innovative figure in Chinese medicine innovation

March 14,2016

On the evening of March 12, 2016, the first ( 2015 ) award ceremony for the most influential brand selection for pharmaceutical innovation in China jointly organized by the People's Network and the China Association for the Promotion of Pharmaceutical Innovation was solemnly held in Beijing. Dr. Lu Xianping was awarded " the most influential innovator" in China's medical innovation in 2015. On the same day, Dr. Lu announced that he would use the innovation award as a seed fund for the innovation award for the discovery of the company's new drug precursor compound.

  The people attended the award ceremony including Academician Sang Guowei, the vice-chairman of the Standing Committee of the 11st National People's Congress and the chief technical officer of the national science and technology major new drug discovery project, Academician Chen Kaixian, the deputy chief technical officer of the national science and technology major new drug discovery project, Ms. Zhao Baige, the member of the Standing Committee of the National People's Congress and the vice-chairman of the Foreign Affairs Committee of the National People's Congress, Niu Yibing, the president of People’s Network, Jiang Hualiang, the director of the Shanghai Institute of Medicine of the Chinese Academy of Sciences and the president of the Chinese Drug Promotion Association, Song Ruilin, the president of the Chinese Drug Promotion Association and others, as well as well-known experts, scholars, entrepreneurs and representatives of the selection activities active in the pharmaceutical industry, who were all over 100 distinguished guests.

The most influential selection activity for Chinese medical innovation focuses on major disease fields and takes the clinical, economic and social value contribution of medicines that do not meet the clinical needs as the measurement standard. It selects and commends medicines, enterprises and figures with " Chinese brand" significance that have made outstanding contributions to Chinese medical innovation during the " 11th five-year plan" and " 12th five-year plan".

The activity has also received widespread attention from the public. According to the statistics of the People's Network, the total number of public votes reached 90.16 million, the number of valid votes was 2.32 million, nearly 200,000 people praised it, and the number of visits to the website reached 165 million.


More Press Releases